Benachour H - Search Results

1

Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels.

El Shamieh S, Herbeth B, Azimi-Nezhad M, Benachour H, Masson C, Visvikis-Siest S. El Shamieh S, et al. Among authors: benachour h. Clin Chim Acta. 2012 Jan 18;413(1-2):34-8. doi: 10.1016/j.cca.2010.11.038. Epub 2010 Dec 7. Clin Chim Acta. 2012. PMID: 21144844

2

Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.

Benachour H, Zaiou M, Herbeth B, Lambert D, Lamont JV, Pfister M, Siest G, Tiret L, Blankenberg S, Fitzgerald PS, Visvikis-Siest S. Benachour H, et al. Pharmacogenomics. 2009 Jun;10(6):951-9. doi: 10.2217/pgs.09.29. Pharmacogenomics. 2009. PMID: 19530962

3

Klotho KL-VS genotype is involved in blood pressure regulation.

Nzietchueng R, El Shamieh S, Benachour H, Labat C, Herbeth B, Ndiaye NC, Masson C, Visvikis-Siest S, Benetos A. Nzietchueng R, et al. Among authors: benachour h. Clin Chim Acta. 2011 Sep 18;412(19-20):1773-7. doi: 10.1016/j.cca.2011.05.032. Epub 2011 Jun 1. Clin Chim Acta. 2011. PMID: 21663735

4

Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors.

Benachour H, Zaiou M, Samara A, Herbeth B, Pfister M, Lambert D, Siest G, Visvikis-Siest S. Benachour H, et al. Nutr Metab Cardiovasc Dis. 2009 Dec;19(10):720-8. doi: 10.1016/j.numecd.2009.01.001. Epub 2009 Apr 5. Nutr Metab Cardiovasc Dis. 2009. PMID: 19346112

5

Functional genomics towards personalized healthcare.

Siest G, Benachour H, Lambert D, Marteau JB, Masson C, Ndiaye NC, Visvikis-Siest S. Siest G, et al. Among authors: benachour h. Per Med. 2009 Jan;6(1):19-32. doi: 10.2217/17410541.6.1.19. Per Med. 2009. PMID: 29783385 No abstract available.

6

From human genetic variations to prediction of risks and responses to drugs and the environment.

Siest G, Bastien B, Benachour H, Herbeth B, Jeannesson E, Lambert D, Samara A, Visvikis-Siest S. Siest G, et al. Among authors: benachour h. Per Med. 2007 Feb;4(1):95-104. doi: 10.2217/17410541.4.1.95. Per Med. 2007. PMID: 29793297 No abstract available.

7

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.

Zaiou M, Benachour H, Marteau JB, Visvikis-Siest S, Siest G. Zaiou M, et al. Among authors: benachour h. Curr Pharm Des. 2009;15(27):3193-206. doi: 10.2174/138161209789058011. Curr Pharm Des. 2009. PMID: 19754391 Review.

8

Non polymeric nanoparticles for photodynamic therapy applications: recent developments.

Chouikrat R, Seve A, Vanderesse R, Benachour H, Barberi-Heyob M, Richeter S, Raehm L, Durand JO, Verelst M, Frochot C. Chouikrat R, et al. Among authors: benachour h. Curr Med Chem. 2012;19(6):781-92. doi: 10.2174/092986712799034897. Curr Med Chem. 2012. PMID: 22214454 Review.

9

Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI.

Benachour H, Sève A, Bastogne T, Frochot C, Vanderesse R, Jasniewski J, Miladi I, Billotey C, Tillement O, Lux F, Barberi-Heyob M. Benachour H, et al. Theranostics. 2012;2(9):889-904. doi: 10.7150/thno.4754. Epub 2012 Sep 29. Theranostics. 2012. PMID: 23082101 Free PMC article.

10

Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach.

Benachour H, Bastogne T, Toussaint M, Chemli Y, Sève A, Frochot C, Lux F, Tillement O, Vanderesse R, Barberi-Heyob M. Benachour H, et al. PLoS One. 2012;7(11):e48617. doi: 10.1371/journal.pone.0048617. Epub 2012 Nov 7. PLoS One. 2012. PMID: 23144911 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page